<DOC>
	<DOCNO>NCT00103792</DOCNO>
	<brief_summary>The purpose study determine efficacy safety new drug , mycophenolate mofetil , treatment relapse ANCA-associated vasculitis ( Wegener 's granulomatosis microscopic polyangiitis ) . Therefore , compare standard therapy cyclophosphamide mycophenolate mofetil . The investigator expect mycophenolate mofetil less toxic almost equally effective cyclophosphamide .</brief_summary>
	<brief_title>Mycophenolate Mofetil Treatment Relapses Wegener 's Disease Microscopic Polyangiitis ( MPA )</brief_title>
	<detailed_description>Treatment ANCA-associated vasculitis consist two phase : remission induction highly effective , also relatively toxic drug , , secondly , remission achieve , maintenance therapy less toxic drug . The standard induction therapy relapse Wegener 's granulomatosis microscopic polyangiitis consist combination cyclophosphamide prednisolone . Although induction therapy effective , toxic well . Searching alternative cyclophosphamide , test efficacy safety new combination therapy mycophenolate mofetil prednisolone . We compare effect safety standard induction therapy new therapy . When relapse occur , patient randomize either standard therapy cyclophosphamide mycophenolate mofetil .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>First second relapse ANCAassociated vasculitis PR3 MPOANCA antibodies present histological proof relapse Adult Severe alveolar bleeding ( imminent ) respiratory failure Renal failure ( serum creatinine &gt; 500 umol/L dialysis ) Maintenance therapy start study consist : cyclophosphamide &gt; 100 mg/day prednisolone &gt; 25 mg/day Intolerance allergy cyclophosphamide , mycophenolate mofetil azathioprine Gravidity inadequate anticonception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Induction therapy</keyword>
	<keyword>ANCA-associated vasculitis</keyword>
	<keyword>Wegener 's granulomatosis</keyword>
	<keyword>microscopic polyangiitis</keyword>
	<keyword>mycophenolate mofetil</keyword>
	<keyword>cyclophosphamide</keyword>
</DOC>